Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinoma
暂无分享,去创建一个
[1] S. Shousha,et al. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. , 1997, Journal of clinical pathology.
[2] M. Dietel,et al. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites , 1996, Histopathology.
[3] C. Taylor,et al. Paraffin section immunocytochemistry for estrogen receptor: The time has come , 1996, Cancer.
[4] J. Feldman,et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol‐based ligand‐binding assays , 1996, Cancer.
[5] L. Dorssers,et al. Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer , 1995, International journal of cancer.
[6] S Detre,et al. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. , 1995, Journal of clinical pathology.
[7] V. Jensen,et al. Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer. , 1995, Journal of clinical pathology.
[8] R W Blamey,et al. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. , 1995, Human pathology.
[9] M. Dowsett,et al. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. , 1994, Journal of clinical pathology.
[10] J M Esteban,et al. Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. , 1994, American journal of clinical pathology.
[11] S. Shousha,et al. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. , 1994, Journal of clinical pathology.
[12] M. Baum,et al. Primary management of carcinoma of the breast , 1993, The Lancet.
[13] E. Wilkinson,et al. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[14] J. Coindre,et al. Production of monoclonal antibodies to human estrogen‐receptor protein (ER) using recombinant ER (RER) , 1993, International journal of cancer.
[15] A. Dc,et al. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer , 1993 .
[16] S. Masood,et al. Immunocytochemical analysis of progesterone receptors in breast cancer. , 1991, American journal of clinical pathology.
[17] S. Shousha,et al. Demonstration of progesterone receptors in paraffin wax sections of breast carcinoma. , 1990, Journal of clinical pathology.
[18] S. Masood,et al. Application of Automated Immunochemistry for Assessing Estrogen and Progesterone Receptors in Patients with Breast Cancer , 1989 .
[19] E. Milgrom,et al. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers. , 1989, The American journal of pathology.
[20] O. Hiort,et al. Immunohistochemistry of estrogen receptor protein in paraffin sections. Effects of enzymatic pretreatment and cobalt chloride intensification. , 1988, American journal of clinical pathology.
[21] I. Christensen,et al. Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease‐free survival, and clinical endocrine response , 1988, Cancer.
[22] K. Rogers,et al. Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology. , 1988, Journal of clinical pathology.
[23] K. Lewin,et al. Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[24] M. Press,et al. Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. , 1988, Endocrinology.
[25] G. Greene,et al. Immunostaining of Estrogen Receptor in Paraffin Sections of Breast Carcinomas Using Monoclonal Antibody D75P3U03B3: Effects of Fixation , 1987, The American journal of surgical pathology.
[26] E. Milgrom,et al. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. , 1987, Cancer research.
[27] J. Said,et al. Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. , 1987, American journal of clinical pathology.
[28] E B Cox,et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.
[29] A. C. Carter,et al. Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response , 1985, Cancer.
[30] H. Muensch,et al. Interference of O.C.T. embedding compound with hormone receptor assays. , 1984, American Journal of Clinical Pathology.
[31] G. Greene,et al. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells , 1984, Nature.
[32] C. Nolan,et al. Monoclonal antibodies to human estrogen receptor. , 1980, Proceedings of the National Academy of Sciences of the United States of America.